Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
abbreviated, absorb, Advisor, anonymized, assay, auristatin, background, bifurcated, biggest, cellular, CEO, charge, charged, checkpoint, CI, closing, Codification, commonly, composition, conference, consultant, consulting, contemplated, cytotoxic, cytotoxicity, deduction, Detailed, dioxygenase, Dr, ejection, embedded, ensuing, enzalutimide, epigenetic, erythropoietin, exfiltrated, exploring, forthcoming, fraction, geography, grip, Hb, hearing, HR, immune, IND, infiltrated, killer, killing, legacy, malignancy, mCRPC, mediated, mezzanine, microenvironment, mild, ml, moderate, monomethyl, monotherapy, MRI, myelosuppressive, NCI, nonredeemable, older, open, oxoglutarate, payload, peak, PET, potent, Prolonged, pseudo, PUL, radiation, randomly, redeemable, regression, resignation, resigned, Revolving, rNPV, role, score, screen, SEPO, showed, smaller, specialist, spoliation, streamline, succeed, supplemental, suppressed, temporary, Thane, TIW, transporting, tumor, Unamortized, unchanged, undertreated, underway, usage, valuable, variant, ventricular, vitro, Wettig, Yu
Removed:
abandon, accomplish, adult, altogether, averaged, boxed, capability, capitalized, cardiac, cerebral, compound, cooperate, cooperation, EMA, embolism, exceeding, fee, forward, heightening, infarction, insider, lung, magnitude, MATTERHORN, MDS, myocardial, NDA, Oy, path, preclude, proportion, revised, stockpile, thromboembolism, transfusion, treating, warehousing
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view